Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...

The world’s first chikungunya vaccine, developed by French pharmaceutical firm Valneva SE, has been approved in the UK by the ...

The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...

Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.

Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...

While Zika has been reported in more than 90 countries, surprisingly little is known about what exactly drives Zika ...

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...